secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2022-08-19T23:59:59+00:00
Accession:  0001213900-22-049677
Event type: debt
Sentiment:  negative
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus Life Sciences obtains $1.9M in related-party loans at 10% to prepay debt
-------------------------------------------------------------------------------

- CEO Yutaka Niihara and wife loaned $1,576,574 net; includes $250k personal funds.
- Two promissory notes ($1,668,751 and $250,000) due Aug 2027, 10% interest monthly.
- Affiliate Hope International Hospice loaned $50,000 on demand note also at 10%.
- Proceeds used to prepay $1,924,819 of third-party indebtedness.
- Further related-party loans beyond previously reported in 2021/2022 filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390022049677/0001213900-22-049677-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390022049677/ea164601-8k_emmauslife.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-049677

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer